kpcczКомплексные проблемы сердечно-сосудистых заболеванийComplex Issues of Cardiovascular Diseases2306-12782587-9537Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”10.17802/2306-1278-2018-7-4S-54-65kpccz-507Research ArticleАНАЛИТИЧЕСКИЙ ОБЗОРANALYTICAL REVIEWМеханическая поддержка кровообращения при чрескожном коронарном вмешательстве высокого рискаMechanical circulatory support in high-risk percutaneous coronary interventionКорнелюкР. А.KornelyukR. A.

Корнелюк Роман Александрович - лаборант-исследователь лаборатории критических состояний, врач анестезиолог-реаниматолог отделения анестезиологии и реанимации НИИКПССЗ; ассистент курса анестезиологии и реаниматологии КГМУ.

650002, Кемерово, Сосновый бульвар, 6, тел.: +79234836510

Kornelyuk Roman A. - assistant at the Laboratory of Critical Conditions, intensivist at the Intensive Care Unit, RICCD; lecturer assistant at the Department of Anesthesiology and Intensive Care, KSMU.

650002, Kemerovo, 6, Sosnovy Blvd., tel.: +79234836510

kornra@kemcardio.ruВерещагинИ. Е.VereshchaginI. E.

Верещагин Иван Евгеньевич - младший научный сотрудник лаборатории интервенционных методов диагностики и лечения атеросклероза.

Сосновый бульвар, 6, Кемерово, Кемеровская область, 650002

Vereshchagin Ivan E. - researcher assistant at the Laboratory for Interventional Methods of Diagnosis and Treatment of Atherosclerosis RICCD.

6, Sosnovy Blvd., Kemerovo, 650002

ШукевичД. Л.ShukevichD. L.

Шукевич Дмитрий Леонидович - доктор медицинских наук, заведующий лабораторией критических состояний.

Сосновый бульвар, 6, Кемерово, Кемеровская область, 650002; Ул. Ворошилова, 22а, Кемерово, Кемеровская обл., 650056

Shukevich Dmitry L. - MD, PhD, Head of the Laboratory of Critical Conditions, RICCD.

6, Sosnovy Blvd., Kemerovo, 650002; 22a, Voroshilova St., Kemerovo, 650056 Highlights

ГанюковВ. И.GanyukovV. I.

Ганюков Владимир Иванович - доктор медицинских наук, заведующий лабораторией интервенционных методов диагностики и лечения атеросклероза НИИКПССЗ.

Сосновый бульвар, 6, Кемерово, Кемеровская область, 650002

Ganyukov Vladimir I. - MD, PhD, Head of the Laboratory for Interventional Methods of Diagnosis and Treatment of Atherosclerosis, RICCD.

6, Sosnovy Blvd., Kemerovo, 650002

Федеральное государственное бюджетное научное учреждение Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний; Федеральное государственное бюджетное образовательное учреждение высшего образования «Кемеровский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases; Federal State Budget Educational Institution of Higher Education «Kemerovo State Medical University» of the Ministry of Healthcare of the Russian FederationRussian FederationФедеральное государственное бюджетное научное учреждение Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийРоссияFederal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular DiseasesRussian Federation20180102201974S5465Copyright © Корнелюк Р.А., Верещагин И.Е., Шукевич Д.Л., Ганюков В.И., 20202020Корнелюк Р.А., Верещагин И.Е., Шукевич Д.Л., Ганюков В.И.Kornelyuk R.A., Vereshchagin I.E., Shukevich D.L., Ganyukov V.I.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nii-kpssz.com/jour/article/view/507

Чрескожное коронарное вмешательство высокого риска подразумевает технические трудности при выполнении реваскуляризации, нестабильность сердечного ритма и гемодинамики и возможные осложнения. Одним из способов обеспечения гемодинамической стабильности и расширения возможностей для реваскуляризации являются использование устройств механической поддержки кровообращения. На данный момент арсенал методов представлен следующими устройствами: внутриаортальная баллонная контрпульсация, Impella, TandemHeart и вено-артериальная мембранная оксигенация. В обзоре рассмотрены актуальные сообщения, данные регистров, рандомизированных и наблюдательных исследований, а также клинические протоколы, посвященные использованию этих устройств для механической поддержки кровообращения во время чрескожного коронарного вмешательства высокого риска.

High-risk percutaneous coronary intervention involves technical challenges in performing revascularization, hemodynamic instability and heart rate variability, and possible complications. Mechanical circulatory support devices ensure hemodynamic stability and expansion of opportunities for revascularization. Current methods include the following devices: intra-aortic balloon counterpulsation, Impella, TandemHeart, and venoarterial extracorporeal membrane oxygenation. The review accumulates current evidences on the use of these devices for mechanical circulatory support during high-risk percutaneous coronary intervention from the reports, registries, randomized and observational studies, as well as clinical trials.

чрескожное коронарное вмешательство высокого рискамеханическая поддержка кровообращениягемодинамикаhigh-risk percutaneous coronary interventionmechanical circulatory supporthemodynamicsReferencesGiacoppo D., Colleran R., Cassese S., Frangieh A.H., Wiebe J., Joner M., Schunkert H., Kastrati A., Byrne R.A. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients with Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis. JAMA Cardiol. 2017;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.Giacoppo D., Colleran R., Cassese S., Frangieh A.H., Wiebe J., Joner M., Schunkert H., Kastrati A., Byrne R.A. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients with Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis. JAMA Cardiol. 2017;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.Myat A., Patel N., Tehrani S., Banning A.P., Redwood S.R., Bhatt D.L. Percutaneous Circulatory Assist Devices for High-Risk Coronary Intervention. JACC Cardiovasc Interv. 2015;8(2):229-244. doi: 10.1016/j.jcin.2014.07.030.Myat A., Patel N., Tehrani S., Banning A.P., Redwood S.R., Bhatt D.L. Percutaneous Circulatory Assist Devices for High-Risk Coronary Intervention. JACC Cardiovasc Interv. 2015;8(2):229-244. doi: 10.1016/j.jcin.2014.07.030.Rihal C.S., Naidu S.S., Givertz M.M., Szeto W.Y., Burke J.A., Kapur N.K., Kern M., Garratt K.N., Goldstein J.A., Dimas V., Tu T.; Society for Cardiovascular Angiography and Interventions (SCAI); Heart Failure Society of America (HFSA); Society of Thoracic Surgeons (STS); American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional CardiologyAssociation Canadienne de Cardiologie d'intervention. J Am Coll Cardiol. 2015; 65(19):e7-e26. doi: 10.1016/j.jacc.2015.03.036.Rihal C.S., Naidu S.S., Givertz M.M., Szeto W.Y., Burke J.A., Kapur N.K., Kern M., Garratt K.N., Goldstein J.A., Dimas V., Tu T.; Society for Cardiovascular Angiography and Interventions (SCAI); Heart Failure Society of America (HFSA); Society of Thoracic Surgeons (STS); American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional CardiologyAssociation Canadienne de Cardiologie d'intervention. J Am Coll Cardiol. 2015; 65(19):e7-e26. doi: 10.1016/j.jacc.2015.03.036.Тарасов Р.С., Неверова Ю.Н., Ганюков В.И., Иванов С.В., Барбараш О.Л., Барбараш Л.С. Результаты реваскуляризации миокарда у пациентов с острым коронарным синдромом без подъема сегмента ST при многососудистом коронарном атеросклерозе. Комплексные проблемы сердечно-сосудистых заболеваний. 2016; 3: 52-58.Tarasov R.S., Neverova Y.N., Ganyukov V.I., Ivanov S.V., Barbarash O.L., Barbarash L.S. Results of myocardial revascularization in patients with non-ST-segment elevation acute coronary syndromes in multivessel coronary atherosclerosis. Complex Issues of Cardiovascular Diseases. 2016; 3: 52-58. (In Russian)Schreuder J.J., Castiglioni A., Donelli A., Maisano F., Jansen J.R., Hanania R., Hanlon P., Bovelander J., Alfieri O. Automatic intra-aortic balloon pump timing using an intrabeat dicrotic notch prediction algorithm. Ann Thorac Surg. 2005; 79 (3): 1017-1022. DOI: 10.1016/j.athoracsur.2004.07.074Schreuder J.J., Castiglioni A., Donelli A., Maisano F., Jansen J.R., Hanania R., Hanlon P., Bovelander J., Alfieri O. Automatic intra-aortic balloon pump timing using an intrabeat dicrotic notch prediction algorithm. Ann Thorac Surg. 2005; 79 (3): 1017-1022. DOI: 10.1016/j.athoracsur.2004.07.074Mulholland J., Yarham G., Clements A., Morris C., Loja D. Mechanical left ventricular support using a 50 cc 8 Fr fibre-optic intra-aortic balloon technology: A case report. Perfusion. 2013 28 (2): 109-113. https://doi.org/10.1177/0267659112454912Mulholland J., Yarham G., Clements A., Morris C., Loja D. Mechanical left ventricular support using a 50 cc 8 Fr fibre-optic intra-aortic balloon technology: A case report. Perfusion. 2013 28 (2): 109-113. https://doi.org/10.1177/0267659112454912Papaioannou T.G., Stefanadis C. Basic principles of the intra-aortic balloon pump and mechanisms affecting its performance. ASAIO J. 2005; 51 (3): 296-300. doi: 10.1097/01.MAT.0000159381.97773.9BPapaioannou T.G., Stefanadis C. Basic principles of the intra-aortic balloon pump and mechanisms affecting its performance. ASAIO J. 2005; 51 (3): 296-300. doi: 10.1097/01.MAT.0000159381.97773.9BRastan A.J., Tillmann E., Subramanian S., Lehmkuhl L., Funkat A.K., Leontyev S., Doenst T., Walther T., Gutberlet M., Mohr F.W. Visceral arterial compromise during intra-aortic balloon counterpulsation therapy. Circulation. 2010; 122 (11 Suppl): S92-S99. doi: 10.1161/CIRCULATIONAHA.109.929810Rastan A.J., Tillmann E., Subramanian S., Lehmkuhl L., Funkat A.K., Leontyev S., Doenst T., Walther T., Gutberlet M., Mohr F.W. Visceral arterial compromise during intra-aortic balloon counterpulsation therapy. Circulation. 2010; 122 (11 Suppl): S92-S99. doi: 10.1161/CIRCULATIONAHA.109.929810Sjauw K.D., Engstrom A.E., Vis M.M., van der Schaaf R.J., Baan J. Jr., Koch K.T., de Winter R.J., Piek J.J., Tijssen J.G., Henriques J.P. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009; 30(4):459-68.doi: 10.1093/eurheartj/ehn602Sjauw K.D., Engstrom A.E., Vis M.M., van der Schaaf R.J., Baan J. Jr., Koch K.T., de Winter R.J., Piek J.J., Tijssen J.G., Henriques J.P. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009; 30(4):459-68. doi: 10.1093/eurheartj/ehn602Mishra S., Chu W.W., Torguson R., Wolfram R, Deible R., Suddath W.O., Pichard A.D., Satler L.F., Kent K.M., Waksman R. Role of Prophylactic Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Percutaneous Coronary Intervention. Am J Cardiol. 2006; 98(5): 608-612. doi: 10.1016/j.amjcard.2006.03.036Mishra S., Chu W.W., Torguson R., Wolfram R, Deible R., Suddath W.O., Pichard A.D., Satler L.F., Kent K.M., Waksman R. Role of Prophylactic Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Percutaneous Coronary Intervention. Am J Cardiol. 2006; 98(5): 608-612. doi: 10.1016/j.amjcard.2006.03.036Briguori C., Sarais C., Pagnotta P., Airoldi F., Liistro F., Sgura F., Spanos V., Carlino M., Montorfano M., Di Mario C., Colombo A. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003 Apr;145(4):700-7. https://doi.org/10.1067/mhj.2003.14Briguori C., Sarais C., Pagnotta P., Airoldi F., Liistro F., Sgura F., Spanos V., Carlino M., Montorfano M., Di Mario C., Colombo A. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003 Apr;145(4):700-7. https://doi.org/10.1067/mhj.2003.14Urban P.M., Freedman R.J., Ohman E., Stone G.W., Christenson J.T., Cohen M. et al. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. The American Journal of Cardiology. 2014; 94 (2): 81-185. https://doi.org/10.1016/j.amjcard.2004.03.058Urban P.M., Freedman R.J., Ohman E., Stone G.W., Christenson J.T., Cohen M. et al. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. The American Journal of Cardiology. 2014; 94 (2): 81-185. https://doi.org/10.1016/j.amjcard.2004.03.058Ferguson J.J. 3rd, Cohen M., Freedman R.J., Stone G.W., Miller M.F., Joseph D.L., Ohman E.M. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38(5):145662.. https://doi.org/10.1016/S0735-1097(01)01553-4Ferguson J.J. 3rd, Cohen M., Freedman R.J., Stone G.W., Miller M.F., Joseph D.L., Ohman E.M. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38(5):145662.. https://doi.org/10.1016/S0735-1097(01)01553-4Stone G.W., Ohman E.M., Miller M.F., Joseph D.L., Christenson J.T., Cohen M. et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: The benchmark registry. J Am Coll Cardiol. 2003;41(11):1940-5. https://doi.org/10.1016/S07351097(03)00400-5Stone G.W., Ohman E.M., Miller M.F., Joseph D.L., Christenson J.T., Cohen M. et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: The benchmark registry. J Am Coll Cardiol. 2003;41(11):1940-5. https://doi.org/10.1016/S07351097(03)00400-5Zeymer U., Bauer T., Hamm C., Zahn R., Weidinger F., Seabra-Gomes R., Hochadel M., Marco J., Gitt A. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. EuroIntervention. 2011;7(4):437-41. doi: 10.4244/EIJV7I4A72Zeymer U., Bauer T., Hamm C., Zahn R., Weidinger F., Seabra-Gomes R., Hochadel M., Marco J., Gitt A. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. EuroIntervention. 2011;7(4):437-41. doi: 10.4244/EIJV7I4A72Barron H.V., Every N.R., Parsons L.S., Angeja B., Goldberg R.J., Gore J.M., Chou T.M.; Investigators in the National Registry of Myocardial Infarction 2. The use of intraaortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141(6):933-9. doi: 10.1067/mhj.2001.115295Barron H.V., Every N.R., Parsons L.S., Angeja B., Goldberg R.J., Gore J.M., Chou T.M.; Investigators in the National Registry of Myocardial Infarction 2. The use of intraaortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141(6):933-9. doi: 10.1067/mhj.2001.115295Perera D., Stables R., Thomas M., Booth J., Pitt M., Blackman D., de Belder A., Redwood S.; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8):867-74. doi: 10.1001/jama.2010.1190.Perera D., Stables R., Thomas M., Booth J., Pitt M., Blackman D., de Belder A., Redwood S.; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8):867-74. doi: 10.1001/jama.2010.1190.Patel M.R., Smalling R.W., Thiele H., Barnhart H.X., Zhou Y., Chandra P., Chew D., Cohen M., French J., Perera D., Ohman E.M. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA; 2011; 306(12):1329-37. doi: 10.1001/jama.2011.1280.Patel M.R., Smalling R.W., Thiele H., Barnhart H.X., Zhou Y., Chandra P., Chew D., Cohen M., French J., Perera D., Ohman E.M. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA; 2011; 306(12):1329-37. doi: 10.1001/jama.2011.1280.Thiele H., Zeymer U., Neumann F.-J., Ferenc M., Olbrich H.-G., Hausleiter J. et al. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N Engl J Med. 2012;367(14):1287-96. doi: 10.1056/NEJMoa1208410.Thiele H., Zeymer U., Neumann F.-J., Ferenc M., Olbrich H.-G., Hausleiter J. et al. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N Engl J Med. 2012;367(14):1287-96. doi: 10.1056/NEJMoa1208410.Basra S.S., Loyalka P., Kar B. Current status of percutaneous ventricular assist devices for cardiogenic shock. Curr Opin Cardiol. 2011; 26(6):548-54. doi: 10.1097/HCO.0b013e32834b803cBasra S.S., Loyalka P., Kar B. Current status of percutaneous ventricular assist devices for cardiogenic shock. Curr Opin Cardiol. 2011; 26(6):548-54. doi: 10.1097/HCO.0b013e32834b803cKapur N.K., Paruchuri V., Urbano-Morales J.A., Mackey E.E., Daly G.H., Qiao X., Pandian N., Perides G., Karas R.H. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation. 2013;128(4):328-36. doi: 10.1161/CIRCULATIONAHA.112.000029.Kapur N.K., Paruchuri V., Urbano-Morales J.A., Mackey E.E., Daly G.H., Qiao X., Pandian N., Perides G., Karas R.H. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation. 2013;128(4):328-36. doi: 10.1161/CIRCULATIONAHA.112.000029.Thiele H., Lauer B., Hambrecht R., Boudriot E., Cohen H.A., Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104(24):2917-22.Thiele H., Lauer B., Hambrecht R., Boudriot E., Cohen H.A., Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104(24):2917-22.Burkhoff D., Cohen H., Brunckhorst C., O'Neill W.W.; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469. e1-8. DOI: 10.1016/j.ahj.2006.05.031Burkhoff D., Cohen H., Brunckhorst C., O'Neill W.W.; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469. e1-8. DOI: 10.1016/j.ahj.2006.05.031Ouweneel D.M., Henriques J.P. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart. 2012;98(16):1246-54. doi: 10.1136/heartjnl-2012-301963.Ouweneel D.M., Henriques J.P. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart. 2012;98(16):1246-54. doi: 10.1136/heartjnl-2012-301963.Kar B., Gregoric I.D., Basra S.S., Idelchik G.M., Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57(6):688-96. doi: 10.1016/j.jacc.2010.08.613.Kar B., Gregoric I.D., Basra S.S., Idelchik G.M., Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57(6):688-96. doi: 10.1016/j.jacc.2010.08.613.Ostadal P., Mlcek M., Holy F., Horakova S., Kralovec S., Skoda J., Petru J., Kruger A., Hrachovina V., Svoboda T., Kittnar O., Reddy V.Y., Neuzil P. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol. 2012;5(6):1202-6. doi: 10.1161/CIRCEP.112.973123.Ostadal P., Mlcek M., Holy F., Horakova S., Kralovec S., Skoda J., Petru J., Kruger A., Hrachovina V., Svoboda T., Kittnar O., Reddy V.Y., Neuzil P. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol. 2012;5(6):1202-6. doi: 10.1161/CIRCEP.112.973123.Gregoric I.D., Bieniarz M.C., Arora H., Frazier O.H., Kar B., Loyalka P. Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J. 2008; 35(1): 46–49.Gregoric I.D., Bieniarz M.C., Arora H., Frazier O.H., Kar B., Loyalka P. Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J. 2008; 35(1): 46–49.Pham D.T., Al-Quthami A., Kapur N.K. Percutaneous left ventricular support in cardiogenic shock and severe aortic regurgitation. Catheter Cardiovasc Interv. 2013;81(2):399-401. doi: 10.1002/ccd.24501.Pham D.T., Al-Quthami A., Kapur N.K. Percutaneous left ventricular support in cardiogenic shock and severe aortic regurgitation. Catheter Cardiovasc Interv. 2013;81(2):399-401. doi: 10.1002/ccd.24501.Thiele H., Sick P., Boudriot E., Diederich K.W., Hambrecht R., Niebauer J., Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276-83. DOI: 10.1093/eurheartj/ehi161Thiele H., Sick P., Boudriot E., Diederich K.W., Hambrecht R., Niebauer J., Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276-83. DOI: 10.1093/eurheartj/ehi161Raess D.H., Weber D.M. Impella 2.5. J Cardiovasc Transl Res. 2009; 2(2): 168-72. doi: 10.1007/s12265-009-9099-4.Raess D.H., Weber D.M. Impella 2.5. J Cardiovasc Transl Res. 2009; 2(2): 168-72. doi: 10.1007/s12265-009-9099-4.Remmelink M., Sjauw K.D., Henriques J.P., de Winter R.J., Vis M.M., Koch K.T., Paulus W.J., de Mol B.A., Tijssen J.G., Piek J.J., Baan J. Jr. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv. 2010;75(2):187-94. doi: 10.1002/ccd.22263.Remmelink M., Sjauw K.D., Henriques J.P., de Winter R.J., Vis M.M., Koch K.T., Paulus W.J., de Mol B.A., Tijssen J.G., Piek J.J., Baan J. Jr. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv. 2010;75(2):187-94. doi: 10.1002/ccd.22263.Remmelink M., Sjauw K.D., Henriques J.P., de Winter R.J., Koch K.T., van der Schaaf R.J., Vis M.M., Tijssen J.G., Piek J.J., Baan J. Jr. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv. 2007;70(4):532-7.Remmelink M., Sjauw K.D., Henriques J.P., de Winter R.J., Koch K.T., van der Schaaf R.J., Vis M.M., Tijssen J.G., Piek J.J., Baan J. Jr. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv. 2007;70(4):532-7.Martinez C.A., Singh V., Londoño J.C., Cohen M.G., Alfonso C.E., O'Neill W.W., Heldman A.W. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction. Catheter Cardiovasc Interv. 2012;80(7):1201-9. doi: 10.1002/ccd.24303.Martinez C.A., Singh V., Londoño J.C., Cohen M.G., Alfonso C.E., O'Neill W.W., Heldman A.W. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction. Catheter Cardiovasc Interv. 2012;80(7):1201-9. doi: 10.1002/ccd.24303.Lauten A., Engström A.E., Jung C., Empen K., Erne P., Cook S., Windecker S., Bergmann M.W., Klingenberg R., Lüscher T.F., Haude M., Rulands D., Butter C., Ullman B., Hellgren L., Modena M.G., Pedrazzini G., Henriques J.P., Figulla H.R., Ferrari M. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6(1):2330. doi: 10.1161/CIRCHEARTFAILURE.112.967224.Lauten A., Engström A.E., Jung C., Empen K., Erne P., Cook S., Windecker S., Bergmann M.W., Klingenberg R., Lüscher T.F., Haude M., Rulands D., Butter C., Ullman B., Hellgren L., Modena M.G., Pedrazzini G., Henriques J.P., Figulla H.R., Ferrari M. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6(1):2330. doi: 10.1161/CIRCHEARTFAILURE.112.967224.Maini B., Naidu S.S., Mulukutla S., Kleiman N., Schreiber T., Wohns D., Dixon S., Rihal C., Dave R., O'Neill W. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv. 2012;80(5):71725. doi: 10.1002/ccd.23403.Maini B., Naidu S.S., Mulukutla S., Kleiman N., Schreiber T., Wohns D., Dixon S., Rihal C., Dave R., O'Neill W. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv. 2012;80(5):71725. doi: 10.1002/ccd.23403.O'Neill W.W., Kleiman N.S., Moses J., Henriques J.P., Dixon S., Massaro J., Palacios I., Maini B., Mulukutla S., Dzavík V., Popma J., Douglas P.S., Ohman M. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717-27. doi: 10.1161/CIRCULATIONAHA.112.098194.O'Neill W.W., Kleiman N.S., Moses J., Henriques J.P., Dixon S., Massaro J., Palacios I., Maini B., Mulukutla S., Dzavík V., Popma J., Douglas P.S., Ohman M. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):171727. doi: 10.1161/CIRCULATIONAHA.112.098194.Cohen M.G., Ghatak A., Kleiman N.S., Naidu S.S., Massaro J.M., Kirtane A.J., Moses J., Magnus Ohman E., Džavík V., Palacios I.F., Heldman A.W., Popma J.J., O'Neill W. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study. Catheter Cardiovasc Interv. 2014;83(7):1057-64. doi: 10.1002/ccd.25277.Cohen M.G., Ghatak A., Kleiman N.S., Naidu S.S., Massaro J.M., Kirtane A.J., Moses J., Magnus Ohman E., Džavík V., Palacios I.F., Heldman A.W., Popma J.J., O'Neill W. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study. Catheter Cardiovasc Interv. 2014;83(7):1057-64. doi: 10.1002/ccd.25277.Dardas P., Mezilis N., Ninios V., Theofilogiannakos E.K., Tsikaderis D., Tsotsolis N., Kolettas A., Nikoloudakis N., Pitsis A.A. ECMO as a bridge to high-risk rotablation of heavily calcified coronary arteries. Herz. 2012;37(2):225-30. doi: 10.1007/s00059-011-3489-5.Dardas P., Mezilis N., Ninios V., Theofilogiannakos E.K., Tsikaderis D., Tsotsolis N., Kolettas A., Nikoloudakis N., Pitsis A.A. ECMO as a bridge to high-risk rotablation of heavily calcified coronary arteries. Herz. 2012;37(2):225-30. doi: 10.1007/s00059-011-3489-5.Koutouzis M., Kolsrud O., Albertsson P., Matejka G., Grip L., Kjellman U. Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. Hellenic J Cardiol. 2010;51(3):271-4.Koutouzis M., Kolsrud O., Albertsson P., Matejka G., Grip L., Kjellman U. Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. Hellenic J Cardiol. 2010;51(3):271-4.Jones H.A., Kalisetti D.R., Gaba M., McCormick D.J., Goldberg S. Left ventricular assist for high-risk percutaneous coronary intervention. J Invasive Cardiol. 2012;24(10):544-50.Jones H.A., Kalisetti D.R., Gaba M., McCormick D.J., Goldberg S. Left ventricular assist for high-risk percutaneous coronary intervention. J Invasive Cardiol. 2012;24(10):544-50.Kawashima D., Gojo S., Nishimura T., Itoda Y., Kitahori K., Motomura N., Morota T., Murakami A., Takamoto S., Kyo S., Ono M. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. SAIO J. 2011;57(3):169-76. doi: 10.1097/MAT.0b013e31820e121c.Kawashima D., Gojo S., Nishimura T., Itoda Y., Kitahori K., Motomura N., Morota T., Murakami A., Takamoto S., Kyo S., Ono M. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. SAIO J. 2011;57(3):169-76. doi: 10.1097/MAT.0b013e31820e121c.Koeckert M.S., Jorde U.P., Naka Y., Moses J.W., Takayama H. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg. 2011; 26(6):666-8. doi: 10.1111/j.1540-8191.2011.01338.x.Koeckert M.S., Jorde U.P., Naka Y., Moses J.W., Takayama H. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg. 2011; 26(6):666-8. doi: 10.1111/j.1540-8191.2011.01338.x.Koutouzis M., Kolsrud O., Albertsson P., Matejka G., Grip L., Kjellman U. Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. Hellenic J Cardiol. 2010;51(3):271-4.Koutouzis M., Kolsrud O., Albertsson P., Matejka G., Grip L., Kjellman U. Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. Hellenic J Cardiol. 2010;51(3):271-4.Arlt M., Philipp A., Voelkel S., Schopka S., Husser O., Hengstenberg C., Schmid C., Hilke M. Early experiences with miniaturized extracorporeal life-support in the catheterization laboratory. Eur J Cardiothorac Surg. 2012;42(5):858-63. doi: 10.1093/ejcts/ezs176Arlt M., Philipp A., Voelkel S., Schopka S., Husser O., Hengstenberg C., Schmid C., Hilke M. Early experiences with miniaturized extracorporeal life-support in the catheterization laboratory. Eur J Cardiothorac Surg. 2012;42(5):858-63. doi: 10.1093/ejcts/ezs176Chen J.S., Ko W.J., Yu H.Y., Lai L.P., Huang S.C., Chi N.H., Tsai C.H., Wang S.S., Lin F.Y., Chen Y.S. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med. 2006; 34(4):950-7. doi: 10.1097/01.CCM.0000206103.35460.1FChen J.S., Ko W.J., Yu H.Y., Lai L.P., Huang S.C., Chi N.H., Tsai C.H., Wang S.S., Lin F.Y., Chen Y.S. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med. 2006; 34(4):950-7. doi: 10.1097/01.CCM.0000206103.35460.1FRicciardi M., Moscucci M., Knight B., Zivin A., Bartlett R., Bates E. Emergency extracorporeal membrane oxygenation (ECMO)-supported percutaneous coronary interventions in the fibrillating heart. Catheter Cardiovasc Interv. 1999;48(4):402-5. https://doi.org/10.1002/(SICI)1522726X(199912)48:4<402::AID-CCD17>3.0.CO;2-3Ricciardi M., Moscucci M., Knight B., Zivin A., Bartlett R., Bates E. Emergency extracorporeal membrane oxygenation (ECMO)-supported percutaneous coronary interventions in the fibrillating heart. Catheter Cardiovasc Interv. 1999;48(4):402-5. https://doi.org/10.1002/(SICI)1522726X(199912)48:4<402::AID-CCD17>3.0.CO;2-3Shammas N., Roberts S., Early G. Extracorporeal membrane oxygenation for unprotected left main stenting in a patient with totally occluded right coronary artery and severe left ventricular. J Invasive Cardiol. 2002;14(12):756-9.Shammas N., Roberts S., Early G. Extracorporeal membrane oxygenation for unprotected left main stenting in a patient with totally occluded right coronary artery and severe left ventricular. J Invasive Cardiol. 2002;14(12):756-9.Fesc G.V., Akret C., Bach V., Barone G., Durand M., Chavanon O., Hacini R., Bouvaist H., Machecourt J., Blin D. Assistance circulatoire extracorporelle percutanée dans les défaillances hémodynamiques aiguës graves: expérience monocentrique chez 100 patients consécutifs [Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients]. Can J Cardiol. 2009; 25 (6): e179-e186.Fesc G.V., Akret C., Bach V., Barone G., Durand M., Chavanon O., Hacini R., Bouvaist H., Machecourt J., Blin D. Assistance circulatoire extracorporelle percutanée dans les défaillances hémodynamiques aiguës graves: expérience monocentrique chez 100 patients consécutifs [Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients]. Can J Cardiol. 2009; 25 (6): e179-e186.Yamauchi T., Masai T., Takeda K., Kainuma S., Sawa Y. Percutaneous cardiopulmonary support after acute myocardial infarction at the left main trunk. Ann Thorac Cardiovasc Surg. 2009;15(2):93-97.Yamauchi T., Masai T., Takeda K., Kainuma S., Sawa Y. Percutaneous cardiopulmonary support after acute myocardial infarction at the left main trunk. Ann Thorac Cardiovasc Surg. 2009;15(2):93-97.O'Gara P.T., Kushner F.G., Ascheim D.D., Casey Jr. D.E., Chung M.K., De Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A., Granger C.B., Krumholz H.M. Linderbaum, J.A. Morrow D.A., Newby L.K., Ornato J.P., Ou N., Radford M.J., Tamis-Holland J.E., Tommaso C.L., Tracy C.M., Woo Y.J., Zhao D.X. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. JACC. 2013; 61 (4):e78 –140. doi:. https://doi.org/10.1016/j.jacc.2012.11.019O'Gara P.T., Kushner F.G., Ascheim D.D., Casey Jr. D.E., Chung M.K., De Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A., Granger C.B., Krumholz H.M. Linderbaum, J.A. Morrow D.A., Newby L.K., Ornato J.P., Ou N., Radford M.J., Tamis-Holland J.E., Tommaso C.L., Tracy C.M., Woo Y.J., Zhao D.X. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. JACC. 2013; 61 (4):e78 –140. doi:. https://doi.org/10.1016/j.jacc.2012.11.019Steg P.G., James S.K., Atar D., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33(20): 2569-619. doi: 10.1093/eurheartj/ehs215Steg P.G., James S.K., Atar D., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33(20): 2569-619. doi: 10.1093/eurheartj/ehs215S. Nuding, K. Werdan. IABP plus ECMO—Is one and one more than two? J Thorac Dis. 2017r; 9(4): 961–964. doi: [10.21037/jtd.2017.03.73]S. Nuding, K. Werdan. IABP plus ECMO—Is one and one more than two? J Thorac Dis. 2017r; 9(4): 961–964. doi: [10.21037/jtd.2017.03.73]Li Y., Yan S., Gao S., Liu M., Lou S., Liu G., Ji B., Gao B. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2018 Sep 24. doi: 10.1093/ejcts/ezy304Li Y., Yan S., Gao S., Liu M., Lou S., Liu G., Ji B., Gao B. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2018 Sep 24. doi: 10.1093/ejcts/ezy304Cheng A., Swartz M.F., Massey H.T. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J. 2013; 59(5): 533-6. doi: 10.1097/MAT.0b013e31829f0e52.Cheng A., Swartz M.F., Massey H.T. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J. 2013; 59(5): 533-6. doi: 10.1097/MAT.0b013e31829f0e52.Meani P., Pappalardo F. The step forward for VA ECMO: left ventricular unloading! J Thorac Dis. 2017; 9(11): 4149–4151. doi: [10.21037/jtd.2017.10.14]Meani P., Pappalardo F. The step forward for VA ECMO: left ventricular unloading! J Thorac Dis. 2017; 9(11): 4149–4151. doi: [10.21037/jtd.2017.10.14]Atkinson T.M., Ohman E.M., O’Neill W.W., Rab T., Cigarroa J.E., Interventional Scientific Council of the American College of Cardiology. A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. JACC Cardiovasc Interv. 2016; 9(9): 871-883. https://doi. org/10.1016/j.jcin.2016.02.046Atkinson T.M., Ohman E.M., O’Neill W.W., Rab T., Cigarroa J.E., Interventional Scientific Council of the American College of Cardiology. A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. JACC Cardiovasc Interv. 2016; 9(9): 871-883. https://doi.org/10.1016/j.jcin.2016.02.046Shlofmitz E., Shlofmitz R. High-Risk Percutaneous Coronary Interventions: First, Do No Harm. JACC Cardiovasc Interv. 2016; 9 (16): 1752-1753. https://doi.org/10.1016/j.jcin.2016.06.014Shlofmitz E., Shlofmitz R. High-Risk Percutaneous Coronary Interventions: First, Do No Harm. JACC Cardiovasc Interv. 2016; 9 (16): 1752-1753. https://doi.org/10.1016/j.jcin.2016.06.014

The authors declare that there are no conflicts of interest present.